When Men Are Sexually Harassed: A Foundation for Studying Men’s Experiences as Targets of Sexual Harassment

While much scholarly attention has been given to sexual harassment, scholarship about men’s experiences as targets of sexual harassment has been limited. This essay is a review of the literature about men’s experiences of sexual harassment; it explores the operational definitions and sources of sexual harassment, the inadequacy of the instruments used to study sexual harassment, and the implications of this research for organizations and the field of communication studies. It also examines sexual harassment at the intersections of gender and sexual orientation, finding that there are apparent differences in incidences that feature diversity in these areas. This review concludes that while psychologists are conducting the majority of sexual harassment research, organizational communication scholars need to do more research about sexual harassment, especially men’s experiences as targets of sexual harassment

A BAYESIAN RANDOM COEFFICIENT NONLINEAR REGRESSION MODEL FOR A SPLIT-PLOT EXPERIMENT

In random coefficients regression, we are often interested in the mean of a certain para-meter particular to the experimental unit (EU). When the mean depends on some treatment regimen, we are then interested in comparing the means among the different treatments. When the EUs are repeatedly measured on a variable containing information about the EU parameter, a standard procedure is to estimate each EU parameter and treat the estimates as the response variables. This is especially true when the regression model for an EU is non-linear. Often, for designed experiments with a factorial treatment structure, the estimated EU parameters are then modeled with an appropriate linear (mixed) model. Here, we consider a split-plot experiment conducted to detect differences in the half-life of a compound between different treatment regimens of the compound, namely compound preparation and temperature (whole-plot factors) and initial compound amount (split-plot factor). Initially, we provide a standard (classical) analysis plan, and then present a Bayes random coefficients regression model to address the researcher’s questions of interest. We finally compare the results from the standard and Bayes analyses

The Science Performance of JWST as Characterized in Commissioning

This paper characterizes the actual science performance of the James Webb Space Telescope (JWST), as determined from the six month commissioning period. We summarize the performance of the spacecraft, telescope, science instruments, and ground system, with an emphasis on differences from pre-launch expectations. Commissioning has made clear that JWST is fully capable of achieving the discoveries for which it was built. Moreover, almost across the board, the science performance of JWST is better than expected; in most cases, JWST will go deeper faster than expected. The telescope and instrument suite have demonstrated the sensitivity, stability, image quality, and spectral range that are necessary to transform our understanding of the cosmos through observations spanning from near-earth asteroids to the most distant galaxies.Comment: 5th version as accepted to PASP; 31 pages, 18 figures; https://iopscience.iop.org/article/10.1088/1538-3873/acb29

Predicting long-term (\u3e or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants.

Although outcome in multiple myeloma (MM) patients has improved significantly with the introduction of autotransplants (AT), the curability of this approach remained to be demonstrated. Therefore, we analysed outcome and prognostic factors using a logistic regression model in 515 consecutive newly diagnosed and previously treated patients intended to receive melphalan-based tandem transplants with follow up of \u3e or = 5 years. One quarter of patients had event-free survivals (EFS) \u3e or = 5 years with no further relapses seen after 7 years (46 patients on plateau). On multivariate analysis, factors associated with EFS \u3e or = 5 years were absence of chromosome 11 and 13 abnormalities (odds ratio: 6.1), \u3c or = 12 months of preceding standard-dose therapy (SDT) (OR: 2.6) and beta-2 microglobulin (B2M) level \u3c or = 2.5 mg/l at time of first AT (OR: 1.7). Patients with only favourable variables (25%) had a 7-year EFS in excess of 35%, compared with 15% and 10%, respectively, with one (43%) or two unfavourable variables (27%), and 0% for 5% of patients with three unfavourable variables (P \u3c 0.0001). Using a 1-year landmark analysis to allow for guaranteed time and thereby excluding early treatment failures, attaining a complete remission (CR) had no significant effect on long-term survival. Our data are consistent with cure in MM patients with a CR duration . or = 7 years and re-establishment of a monoclonal gammopathy of undetermined significance (MGUS) phase in those with persistent evidence of disease post transplantation, but without disease progression \u3e or = 7 years